Biologics and Biosimilars Interchangeability: A Deep Dive with Industry Experts

The ACMA takes a detailed look into the world of biologics and biosimilars with industry experts Sonia Tadjalli Oskouei, PharmD, BCMAS, DPLA and Sarah Ikenberry.

In this webinar, our presenters cover the latest guidelines regarding biologics and biosimilar interchangeability, provide FDA guidance on the clinical use of biosimilars, and address the educational gaps among healthcare providers.

Oskouei serves as Vice President of Biosimilars at Cardinal Health, where she leads the organization's national biosimilars strategy. Ikenberry is the Senior Communication Advisor for the Office of Therapeutic Biologics and Biosimilars in the Food and Drug Administration’s (FDA) Center for Evaluation and Research.

Dr. Kiana Dixson, PharmD, BCMAS hosts the discussion.

To learn more about becoming a Board Certified Biologics and Biosimilars Specialist Program (BCBBS)™, visit https://www.medicalaffairsspecialist....

#ACMA #MSL #medicalscienceliaison #medicalaffairs #Pharmacovigilance #HEOR #medicalinformation #biologics #biosimilars #BCBBS #certification #MSL #Biosimilar #Biosimilars #Interchangeability #Pharma #Pharmaceutical #BioTech #Pharmacist #pharmd